Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis

BACKGROUND: Neoadjuvant chemoradiation therapy for locally unresectable and borderline resectable pancreatic cancer may allow some patients to a undergo a resection, but whether or not this increases post-operative morbidity remains unclear. METHODS: The post-operative morbidity of 29 patients with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Araujo, Raphael L C, Gaujoux, Sébastien, Huguet, Florence, Gonen, Mithat, D'Angelica, Michael I, DeMatteo, Ronald P, Fong, Yuman, Kingham, T Peter, Jarnagin, William R, Goodman, Karyn A, Allen, Peter J
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3731577/
https://ncbi.nlm.nih.gov/pubmed/23458208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hpb.12033
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares